Medicating inhibitory control? Treatment with serotonergic antidepressants predicts stop-N200 amplitudes in major depressive disorder.
Psychological medicine · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansMaleFemaleMajor Depressive DisorderAdultElectroencephalographyInhibition, PsychologicalMagnetic Resonance ImagingAnxiety DisordersEvoked PotentialsSelective Serotonin Reuptake InhibitorsAntidepressive AgentsYoung AdultMiddle AgedSSRIs/SNRIsevent-related potentials (ERPs)major depression disorder (MDD)optimal full propensity matchingstop signal task (SST)Event-related potentials (ERPs)Major Depression Disorder (Mdd)Optimal Full Propensity MatchingSsris/snrisStop Signal Task (Sst)
Come citare questo studio
Vaught WJB, Mann E, Ren X, Tomm RJ, Wilhelm RA, Torres MP, Aupperle RL, Guinjoan S, Stewart JL, Paulus MP, White EJ. (2026). Medicating inhibitory control? Treatment with serotonergic antidepressants predicts stop-N200 amplitudes in major depressive disorder.. Psychological medicine. DOI: 10.1017/s0033291726106394
Consulta la pubblicazione originale ↗